Pharmacovigilance is a scientific and practical activity aimed at the detection, assessment, understanding, and prevention of adverse reactions and adverse events associated with the use of medicinal products and medical devices.

The pharmacovigilance system is designed to protect the health of patients and the public, ensure continuous evaluation of the benefit–risk balance of medicinal products and medical devices, and promote their safe use.

Main objectives of pharmacovigilance:

• prevention of adverse reactions and adverse events arising from the use of authorized medicinal products and medical devices, as well as from exposure related to professional activities;
• ensuring patient safety through early detection and assessment of risks;
• ensuring the safe and effective use of medicinal products and medical devices;
• providing timely and reliable information on the safety of medicinal products and medical devices to healthcare professionals, patients, and the public.

Contact information:

For inquiries related to pharmacovigilance, you may contact:

+998 (71) 203-01-01 (ext. 2357)

For answers to frequently asked questions on pharmacovigilance, adverse reactions, and reporting procedures:

[Frequently Asked Questions (FAQ)]

---

Форма карты сообщения о выявленной нежелательной реакции при применении лекарственного средства.

---